A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors

Published:2019-09 Issue:3 Volume:270 Page:422-433
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Zaidi Mohammad Y.,Lopez-Aguiar Alexandra G.,Switchenko Jeffrey M.,Lipscomb Joseph,Andreasi Valentina,Partelli Stefano,Gamboa Adriana C.,Lee Rachel M.,Poultsides George A.,Dillhoff Mary,Rocha Flavio G.,Idrees Kamran,Cho Clifford S.,Weber Sharon M.,Fields Ryan C.,Staley Charles A.,Falconi Massimo,Maithel Shishir K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference45 articles.

1. Differences in survival by histologic type of pancreatic cancer;Fesinmeyer;Cancer Epidemiol Biomarkers Prev,2005

2. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors;Halfdanarson;Endocr Relat Cancer,2008

3. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications;Strosberg;Ann Surg,2012

4. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

5. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors;Metz;Gastroenterology,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world effectiveness of adjuvant octreotide therapy in patients with pancreatic neuroendocrine tumors at high recurrence risk: A multicenter retrospective cohort study;Journal of Neuroendocrinology;2024-09-10

2. Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study;British Journal of Surgery;2024-08-30

3. Consensus on the clinical diagnosis and treatment of grade 3 pancreatic neuroendocrine tumors;Journal of Pancreatology;2024-04-25

4. Impact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review;Annals of Surgical Oncology;2024-04-23

5. Prognostic value of inflammation‐related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta‐analysis;Journal of Neuroendocrinology;2024-03-11